ACORDA THERAPEUTICS INC (ACOR) Stock News
NASDAQ:ACOR - Nasdaq - US00484M7002 - Common Stock - Currency: USD
ACOR Latest News, Press Relases and Analysis
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Acorda Therapeutics Announces Nasdaq Delisting Notification
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic this morning as we check out all of the biggest news worth reading about on Wednesday morning!
Ubisoft Layoffs 2024: What to Know About the Latest Round of Ubisoft Job Cuts
Ubisoft layoffs were announced for 45 of the company's employees as it streamlines its global publishing and Asia-Pacific units.
GOEV Stock Alert: Canoo Announces Expansion Into Saudi Arabia
Canoo stock is falling on Tuesday even as GOEV investors in the EV company learn of its latest expansion into Saudi Arabia.
Why Is Gritstone Bio (GRTS) Stock Down 44% Today?
Gritstone Bio stock is falling on Tuesday after the biotechnology company priced an underwritten public offering for GRTS shares.
Why Is Acorda Therapeutics (ACOR) Stock Down 72% Today?
Acorda Therapeutics stock is falling hard on Tuesday after the company announced a bankruptcy filing and stalking horse bid agreement.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday!
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
Acorda to regain global commercialization rights to FAMPYRA by Jan 2025 (NASDAQ:ACOR)
Acorda Therapeutics announced it will regain global commercialization rights to FAMPYRA, a treatment for multiple sclerosis, following the termination of...
